CI-1011 is primarily used in medical research for studying cancer treatments, particularly in inhibiting the growth of cancer cells due to its properties that disrupt cancer cell division processes. It is investigated for its potential therapeutic effects in targeting specific biological pathways related to oncology. Researchers evaluate its efficacy in preclinical models, often in combination with other chemotherapy agents, to enhance treatment efficacy, reduce side effects, and determine suitability for further drug development. Current studies focus on developing optimal drug formulations and delivery methods to achieve the best therapeutic outcomes. This compound advances medicinal chemistry and contributes to the discovery of new cancer treatments.